BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

986 related articles for article (PubMed ID: 25966423)

  • 1. Epidemiology of cholangiocarcinoma.
    Bergquist A; von Seth E
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
    Saca D; Flamm SL
    Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
    Fung BM; Tabibian JH
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):487-496. PubMed ID: 33682586
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholangiocarcinoma in primary sclerosing cholangitis.
    Abbas G; Lindor KD
    J Gastrointest Cancer; 2009; 40(1-2):19-25. PubMed ID: 19705300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Fung BM; Tabibian JH
    Curr Opin Gastroenterol; 2020 Mar; 36(2):77-84. PubMed ID: 31850928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Fevery J; Verslype C; Lai G; Aerts R; Van Steenbergen W
    Dig Dis Sci; 2007 Nov; 52(11):3123-35. PubMed ID: 17431781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment.
    Sahu R; Sharma P; Kumar A
    J Gastrointest Cancer; 2023 Mar; 54(1):213-226. PubMed ID: 35023010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
    Duggan WP; Brosnan C; Christodoulides N; Nolan N; Kambakamba P; Gallagher TK
    Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance in cholangiocellular carcinoma.
    Wirth TC; Vogel A
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):987-999. PubMed ID: 27938792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.
    Charbel H; Al-Kawas FH
    Curr Gastroenterol Rep; 2011 Apr; 13(2):182-7. PubMed ID: 21271364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.